Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
IVD and companion diagnostics regulatory consultancy and CRO
ARC Regulatory is a contract research organisation and regulatory consultancy specialising in in vitro diagnostics and companion diagnostics for precision medicine clinical trials. The company provides regulatory strategy, clinical trial management, quality management, and assay validation services to pharmaceutical…
Preclinical to late-phase imaging and eClinical trial services
Perceptive is a contract research organisation providing imaging and eClinical services to pharmaceutical and biotechnology companies across the full drug development lifecycle. Its three divisions cover preclinical and in vivo imaging, clinical trial imaging core lab and independent central review, and randomisation…
AI-driven mass spectrometry biomarker services for diagnostics and drug development
Guilford Street Laboratories Ltd is a contract research organisation providing machine learning-powered mass spectrometry services for biomarker discovery, assay development, and precision medicine. The company specialises in high-sensitivity multi-omic analysis of protein, lipid, and metabolite biomarkers, supporting…
Active protease biomarker assays for respiratory disease diagnostics
ProAxsis is a diagnostics company developing and supplying laboratory immunoassays and point-of-care tests for the measurement of active protease biomarkers in respiratory disease. Using patented activity-based capture technology, the company's assays quantify neutrophil elastase and proteinase 3 as indicators of…
External quality assessment for clinical genomics laboratories
GenQA is a not-for-profit provider of external quality assessment and proficiency testing for clinical genomics laboratories. Its schemes assess analytical and interpretive performance across next-generation sequencing, molecular pathology, reproductive genetics, pharmacogenomics and inherited disease testing. The…
Portable PCR platform for decentralised genetic testing anywhere
Hyris is a biotechnology company developing a portable, IoT-integrated PCR platform for decentralised nucleic acid testing outside traditional laboratory settings. Its instrument runs proprietary assay cartridges and connects to a cloud-based software platform providing real-time results via a dedicated app. An open…
Blood group reference testing, antibody reagents and assay development
IBGRL comprises NHS Blood and Transplant laboratories in Filton, Bristol, providing specialist blood group reference testing, transfusion research and biological reagents. Its red cell reference team investigates complex antibody and antigen cases, while IBGRL Research Products supplies monoclonal antibodies and…
Purified allergens, test kits, and environmental allergen testing
InBio is a biotechnology company specialising in the manufacture of highly purified allergens, antibodies, and immunoassay kits for allergy research, diagnostics, and environmental monitoring. Its Cardiff laboratory provides contract allergen testing services for environmental and food allergen exposure assessment,…
Preimplantation and prenatal genetic testing for reproductive medicine
Juno Genetics is a specialist reproductive genetics laboratory providing preimplantation genetic testing (PGT) services to IVF clinics in the UK and internationally. Using its proprietary next-generation sequencing platform, the company screens embryos for chromosomal abnormalities and single-gene disorders, and…
AI-powered retinal biomarker platform for early detection of eye and brain disease
Novai is a biotechnology company commercialising DARC (Detection of Apoptosing Retinal Cells), a retinal biomarker platform combining a fluorescent biologic with an AI image analysis algorithm to detect single-cell apoptosis in the retina in vivo. FDA and MHRA approved as an exploratory biomarker, DARC enables early…
Menstrual blood biomarker test for gynaecological condition diagnosis
Woost is a biotechnology company developing a home test kit and AI-assisted digital platform that uses menstrual blood as a diagnostic matrix for gynaecological conditions. The platform enables women to track condition-relevant biomarkers from self-collected samples, with initial focus on polycystic ovary syndrome.…
Evidence-based biomedical AI for precision health applications
Pharmatics is a biomedical software company developing evidence-informed artificial intelligence models for digital health and precision medicine. Its MedAI platform combines clinical data with findings from biomedical literature to generate predictive models, risk scores and decision-support tools. Services include…
Real-world clinical data platform for life science research
Arcturis is a real-world data and evidence company that aggregates longitudinal, secondary-care patient records from a network of NHS hospitals into research-ready, regulatory-grade datasets. The platform combines structured and unstructured clinical data with molecular and genomic information, and is supported by HRA…
Glycan-based biological age and inflammaging diagnostics
GlycanAge is a biotechnology company that develops and sells diagnostic tests based on IgG glycan biomarkers. Its flagship product analyses glycans from a finger-prick blood sample to determine a customer's biological age, reflecting the degree of chronic inflammation driving immune ageing. Tests are available…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative PCR results directly from a dry swab in six to ten minutes with no sample preparation, targeting respiratory infections including influenza…
NGS liquid biopsy testing for cancer in dogs and cats
CanCan Diagnostics is a veterinary biotechnology company developing next-generation sequencing tests for cancer detection and monitoring in companion animals. Its K9 LiquiDx liquid biopsy analyses tumour-associated mutations in circulating cell-free DNA from canine blood samples. The company also offers tissue-based…
Single-molecule fluorescence platform for rapid point-of-care pathogen detection
Pictura Bio is a medical technology company developing a rapid diagnostic platform that combines single-molecule fluorescent microscopy with deep learning to identify pathogens in clinical samples in under one minute. The platform uses a universal fluorescent label and a trained AI model to detect any known pathogen…
Clinical chemistry reagents and diagnostic products for human and veterinary use
Glenbio is a Northern Ireland-based manufacturer of in vitro diagnostic reagents, specialising in clinical chemistry reagents and liquid stable protein formulations for use across multiple analyser platforms. Operating from ISO 13485-accredited manufacturing and testing facilities in Antrim, the company supplies…
UK manufacturer of microbiological culture media and donor blood products
E&O Laboratories is the UK's largest privately owned manufacturer of ready-to-use microbiological culture media, dehydrated culture media, antibiotic supplements, and donor animal blood products. Operating from two cGMP manufacturing sites in Scotland, the company supplies clinical, veterinary, pharmaceutical, and…
Synthetic mycolic acid antigens and point-of-care TB diagnostics
Diagnostig is a Welsh diagnostics and chemical synthesis company developing point-of-care immunoassay devices for the diagnosis of mycobacterial infections, including human and bovine tuberculosis. The company's technology is based on fully synthetic mycolic acids, chemically defined cell wall components unique to…